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THE carrageenan pleurisy model, which is characterized
by cellular influx and oedema, has been used to examine
the effects of anti-inflammatory compounds such as na-
proxen. Interleukin-lt and ]] (IL-1) are known to be
pro-inflammatory mediators, and their roles in this model
are unknown. Intrapleural injection of 1% viscarin carra-
geenan or saline was administered to male Lewis rats.
Four to 24 h later, cell counts, fluid volumes and IL-1]]
levels (measured by ELISA) were determined in the pleur-
al cavity. Serum corticosterone levels were measured only
at 4 h. Significant increases in IL-1] levels precede cell
influx suggesting IL-I plays a role in the maintenance of
cell accumulation in the pleural cavity. None of the drugs
tested, including the IL-1 receptor antagonist, maintained
pleural cell influx and IL-1I levels at control levels. When
human IL-lt or l] or rat IL-1]] were injected individually
into the pleural cavity, none of these cytokines were
pro-inflammatory, as measured by increased cell influx
and fluid extravasation. These results suggest that al-
though IL-1I levels increase in the pleural cavity in
response to carrageenan, IL-1 per se is not the initiator of
the pro-inflammatory events of cell influx and oedema in
this model.
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Introduction
The components of inflammation include leuko-
cyte infiltration and fluid accumulation which
accompany the cardinal signs of inflammation such
as heat, swelling, redness and pain. Many mediators,
including lipids, proteinases, biogenic amines, and
peptides have been implicated in this process. In
order to investigate the roles of such mediators,
many animal models have been developed. One
such model is carrageenan induced pleurisy in the
rat, in which the phlogistic agent is usually viscarin
carrageenan. This model has been extensively
studied, has the advantage of being versatile, and
has been used to evaluate standard anti-inflam-
1-5 matory agents.
Using the carrageenan pleurisy model the
potential involvement of interleukin-l(IL-1), a
cytokine which is a known pro-inflammagen,
6 has
been investigated. Among its many activities IL-1
can stimulate cells to induce synthesis of other
cytokines,v increase activity of enzymes such as
phospholipase A2, 8’9 and is responsible for the
accumulation of neutrophils at the sites of
inflammation.1 The exact role of IL-1 in the
inflammatory process induced by carrageenan is still
unclear. The purpose of this study was to
investigate the role of IL-1 and the IL-1 receptor
antagonist in this model.
(C) 1993 Rapid Communications of Oxford ktd
Materials and Methods
Reagents: Human and rat IL-1 0 and /g, human
1L-1 receptor antagonist (rhIL-lra), and rabbit
polyclonal anti-mouse IL-1 antibodies were pre-
pared at The Du Pont Merck Pharmaceutical
Co. All other reagents were purchased from Sigma
Chemical Company, St. Louis, MO, or through
VWR, and were reagent grade.
Pleurisy: Male rats (Lewis rats, LEW/Crl BR
Charles River Laboratories, Wilmington, MA)
weighing 200-250 g were divided into groups of
ten. The procedures have been described previous-
ly.
1-4 Pleurisy tests were carried out using either rats
fasted for 16 h prior to the study or rats fed ad
libitum. Animals were treated orally with appropri-
ate drugs or subcutaneously with the rhIL-lra 1 h
prior to the introduction of the inflammagen.
Animals were anaesthetized with ether and placed
left side down and injected intrapleurally with
0.2 ml of 1% viscarin carrageenan (Sigma Chemical
Co.) or rat IL-1//, human IL-10 or fl at doses
described. Four to 24 h after injection animals were
euthanized using COg. An intercostal incision was
made in the pleural cavity, the cavity lavaged with
6 ml of 0.9% NaC1, exudate volumes recorded, and
fluids centrifuged at 658 x g" (Sorvall RC5C, Du
Pont, Newtown, CT) for 10 min at 5C. Samples
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overtly bloody were discarded. A 1 ml sample of
supernatant was saved and stored at 4C for
determination of IL-lfl levels by ELISA. The
remaining supernatant was decanted and cells
resuspended in 2 ml of 0.9% NaC1 containing 2%
heparin. Aliquots were used to determine total cell
(Coulter Counter, Coulter Corp, Hialeah, FL) and
differential cell counts using Wright’s stain.
Changes in fluid volumes were calculated as the
difference between the initial 6 ml used for the
lavage and the final volume recovered from the
pleural cavity.
ELISA: A sandwich ELISA,
11 using a polyclonal
rabbit antiserum obtained by immunization with
murine recombinant IL-lfi, was used to measure the
IL-lfl levels from the rat pleural cavities. The
microtitre wells were coated with a protein A
purified rabbit-anti-mlL-lfl lgG (20#g/ml in
phosphate buffered saline) at room temperature for
1 h. The wells were washed with Dulbecco’s
phosphate buffered saline. Volumes (100 #1) of
sample or known recombinant IL-lfl dilutions were
added to the wells, followed by a 2 h incubation at
room temperature. The washing step was repeated,
and 100#1 of the biotinylated affinity-purified
rabbit-anti-mIL-lfi antibody was added and allowed
to incubate at room temperature for 1 h. The
optimal dilution of this secondary antibody was
determined by titre prior to the assay. The assay
was developed using avidin coupled to alkaline
phosphatase followed by p-nitrophenyl phosphate
substrate. Incubation was continued at room
temperature for 90 min, and the plates were read at
405 nm (UV Kinetics microplate reader, Molecular
Devices Corp., Menlo Park, CA). The concentra-
tion of IL-lfl in the samples was calculated from
the IL-lfl standard curve. This assay was specific
for IL-lfl; IL-10 and the rhIL-lra did not
cross-react. The lower level of detection for IL-lfl
was 0.1 ng/ml.
Recombinant human and rat IL-lo and fl and recombinant
human IL-1 receptor antagonist: All IL-1 proteins
12 and
the rhIL-lra were produced in Escherichia coli and
purified by standard column chromatography
methods. Samples were tested for endotoxin using
the LAL assay (Whittaker M.A. Bioproducts) with
all preparations shown to contain less than
10 EU/mg of protein. The characteristics of the
rhlL-lra were identical to those published pre-
viously.
3
Corticosterone levels: Blood was collected into vacutain-
ers containing sodium heparin from anaesthetized
animals via heart puncture. Plasma samples were
obtained by centrifugation for 10 min at 658 x g’.
Samples were assayed using an RIA for corticoster-
one, the major glucocorticoid in rat plasma
(MetPath Inc., Rockville, MD). The normal range
for this assay is 10-60 ng/ml.
4
Statistical analysis" Data are expressed as mean-k-
standard error of the mean, determined by analysis
of variance followed by Duncan’s multiple range
test (SAS Institute, Cary, NC). Statistical signifi-
cance was considered to be p < 0.05.
Results
Time course: Figure 1A shows the response to
carrageenan over a 24 h time course. Cell influx
increased 13-fold from 1 x 107 cells/ml (30min)
to 1.3 x 108 cells/ml (4 h) and remained elevated
through 24 h (1.4 108 cells/ml) (p < 0.05). At
4 h the cells present were >90% PMN’s and by
24 h > 50% mononuclear cells were found. These
percentages are consistent with previous findings.
2
Fluid extravasation significantly increased from
0.2 ml in saline treated animals to a maximum of
2.5 ml in carrageenan treated animals after 16 h
(p < 0.05). Cell influx remained constant through
24 h, while fluid volume changes significantly
decreased from 16 through 24 h (p < 0.05).
Figure 1B shows IL-lfl levels in response to
carrageenan. IL-fl increased 2.4-fold from 0.3 ng/ml
(30 min) to 0.72 ng/ml (1 h), and remained elevated
through 6 h (0.54 ng/ml), returning to background
by 16 h (0.15 ng/ml) (p < 0.05). The changes in the
IL-lfl levels in the pleural cavity occurred quickly,
and preceded the changes in cell influx or fluid
volumes.
Drugs: The anti-inflammatory drugs dexamethasone,
piroxicam, and naproxen were tested in this model
at 4 h, a time at which cells, fluid volume and IL-lfl
levels were significantly elevated in the carrageenan
treated rats. None of these drugs maintained cell
influx and fluid volumes at control levels. At all
doses tested, cell influx was approximately midway
between the saline and the carrageenan treated
animals (Fig. 2A). (Dexamethasone was dosed
from 0.01-10 mg/kg; piroxicam was dosed from
1-10mg/kg; naproxen was dosed at 40 and
100 mg/kg.) Fluid extravasation was significantly
reduced in all drug doses by 15%, which was
equivalent to 0.7 ml (data not shown).
IL-lfl levels decreased in the drug treated rats,
but not in a dose dependent manner. Dexa-
methasone decreased IL-lfl levels by 64%, from
0.62 ng/ml at 0.03 mg/kg to 0.21 ng/ml at 1 mg/kg
< 0.05). Piroxicam did not significantly reduce
IL-1 levels (0.51 ng/ml). Naproxen, tested at a
single dose of 40 mg/kg, reduced IL-lfl levels by
35%, from 0.51 ng/ml (controls) to 0.33 ng/ml at
40 mg/kg (Fig. 2B).
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FIG. (A) Time course of cell influx and fluid extravasation in the pleural cavity. Cell influx
was measured in both saline treated (----) and carrageenan treated (--0--) animals.
Fluid volume changes in carrageenan treated animals (--) is shown with no differences
at any time with saline treated control (data not shown). Each time point represents
mean _+ S.E.M." n 4. Curves are significantly different from 2-24 h for both cell influx and
change in volume for carrageenan treated animals compared with saline treated controls
(p < 0.05). (B) Time course of IL-lfl levels in the pleural cavity with carrageenan treated
(--0--) or saline treated (-I-) animals. Each time point represents mean -t- S.E.M n 4.
Curves are significantly different from 0.5-10 h (p < 0.05).
rhIL-lra: The rhIL-lra also maintained cell influx
approximately midway between the saline and
carrageenan controls (Fig. 2A). The maximum
reduction in cell influx was observed at the 1 mg/kg
dose, decreasing the cells from 9.5 x 107 cells/ml to
7.3 x 107 cells/ml (23%; NS). The rhlL-lra sig-
nificantly (p < 0.05) increased IL-lfi levels from
0.50 ng/ml to 0.78 ng/ml at 40 mg/kg in a non-dose
dependent manner (Fig. 2B).
Fed versus fasted rats: Fasting is a form of stress, and
both plasma corticosterone and IL-1 levels may
increase with stress.
14 The effect of fasting on total
cell counts, fluid extravasation and IL-lfl levels in
the pleural cavity, and plasma corticosterone levels
was investigated. The saline treated fed or fasted
animals each had a total cell count of 1.5-1.7 x 107
cells/ml. We compared total cell counts, fluid
extravasation and IL-lfl levels in rats fed ad libitum
and rats fasted for 16 h dosed with rhIL-lra. In
fed animals total cell counts ranged from 1.2 +
0.3 x 108 cells/ml (carrageenan treated) to 7-F
0.5 x 107 cells/ml with animals dosed with 80
mg/kg rhlL-lra (p < 0.05). In fasted animals total
cell counts ranged from 1.0 + 0.03 x 108 cells/ml
(carrageenan treated) to 7.0 -F 1.3 x 107 cells/ml in
animals dosed with 10 mg/kg rhlL-ra (p < 0.05;
Fig. 3). There were no significant increases in
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FIG. 2(A) Effect of dexamethasone (-O-), naproxen (-,-), piroxicam (-x-) and the
rhlL-lra (-A-) on cell influx in the pleural cavity. Each dose represents mean ___
S.E.M.’
n 4-11. All curves are significantly different from both the carrageenan and saline groups
(p < 0.05). (B) Effect of dexamethasone, naproxen, piroxicam and the rhlL-lra on IL-lfl
levels in the pleural cavity. Each dose represents mean _+ S.E.M.; n 4-11. Compared with
the carrageenan control (p < 0.05).
fluid volumes with any of the dosing regimens in
the carrageenan treated fasted or fed rats compared
with saline treated controls (data not shown). IL-1/
levels in lavaged pleural cavities from fed animals
dosed with rhIL-lra were significantly increased
compared with saline controls, returning toward
controls with 80 mg/kg (Table 1). Fasted animals
had IL-lfl levels ranging from 0.40-+-0.04 ng/ml
(carrageenan treated animals) to 0.79 -+-0.14 ng/ml
in animals dosed with 20 mg/kg rhIL-lra. All IL-lfl
levels were significantly increased compared with
saline controls (0.25 _+ 0.01 ng/ml) (Table 1).
Corticosterone levels" Plasma levels were measured in
the fed and fasted rats as an indication of stress
(Table 2). Normal rat corticosterone levels range
from 10 to 60 ng/ml.
14 The rhIL-lra had no effect
on plasma corticosterone levels in fasted rats. The
fed carrageenan treated animals had corticosterone
levels of 485-+-21 ng/ml. In fed animals, as the
doses of rhIL-lra increased from 3 to 80 mg/kg,
corticosterone levels decreased from 502 + 35
ng/ml to 42 +_ 7 ng/ml in a dose dependent manner
(Table 1;p < 0.05), returning to the normal range.
In comparison, in fasted animals corticosterone
levels did not decrease in a dose dependent manner
(Table 2); nor did the corticosterone levels return
to the normal range (10-60ng/ml), even at
80mg/kg. At 40 and 80mg/kg rhIL-lra, the
corticosterone levels were significantly increased in
the fasted animals compared with the fed ones.
These data demonstrate that carrageenan admin-
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FIG. 3. Total cells lavagable from the pleural cavity of rats fed ad libitum or fasted for
16 h prior to carrageenan injection with or without rhlL-1 ra. n 6. Compared with
the carrageenan controls (p < 0.05).
istration significantly increases plasma corticoster-
one and the stress of fasting increases the variability
of the plasma corticosterone levels.
Intrapleural injection of human IL-lfl or 0 or rat IL-lfl:
IL-lfl (human and rat) and IL-1 (human) were
injected intrapleurally to determine if any of these
cytokines are pro-inflammagens by themselves.
There were no significant changes in cell influx or
fluid volumes from 30 min to 24 h with any of the
cytokines tested in doses ranging from 0.001-100
/2g/rat for human and rat IL-lfl and 50-200 #g/rat
for human IL-10 (Fig. 4).
Discussion
Carrageenan is an irritant which sets up a cascade
of events that leads to cell and fluid influx in the
pleural cavity, as described previously.
1-s Small
blood vessels in the subpleural tissues become more
permeable, allowing serum proteins, proteinases
Table 1. L-lfl levels in male Lewis rats fasted 16 h or fed ad
libitum
IL-lfl Levels (ng/ml)
Treatment Fasted Fed
Carrageenan control
Saline control
Carrageenan + rhlL-lra
(mg/kg)
0.40 -t- 0.04* 0.29 _+ 0.03*
0.25 _+ 0.01 0.18 _+ 0.01
3.0 0.52 _+ 0.03* 0.27 ___
0.03*
10.0 0.68 + 0.07* 0.31 + 0.03*
20.0 0.79 +_ 0.14" 0.32 +_ 0.03"
40.0 0.39 + 0.01 0.38 + 0.04*
80.0 0.40 _+ 0.04* 0.24 _+ 0.03
*p < 0.05 compared with saline controls.
n=5.
such as complement, and cells to move into the
pleural cavity. The serum complement components
may be responsible for the cell influx, since many
are chemotactic. Complement inhibitors are active
in this model within the first hour after the
administration of the carrageenan. The purpose of
the present study was to further characterize the
model by examining the possible role of IL-1.
The total number of cells recoverable from the
pleural cavity at the end of 4h was 1.2 108
cells/ml, which is consistent with the cell influx
reported 6 h after carrageenan administration.
2
IL-lfl levels were maximum at 1 h, preceding the
maximal influx of cells. However, cells remained
elevated for 24 h, by which time 1L-1 levels had
returned to control. This observation suggests that
IL-1 may play a role in attracting cells into the
pleural cavity.
Since IL-1 was present in the pleural cavity, the
possibility that the IL-1 receptor antagonist affected
Table 2. Plasma corticosterone levels in male Lewis rats
Corticosterone levels (ng/ml)
Treatment Fasted Fed
Carrageenan control
Saline control
Carrageenan + rhlL-1 ra
(mg/kg)
415 _+ 46* 485 _+ 21
168 +_ 68 290 +_ 72
3.0 391 + 39* 502 + 35*
10.0 331 _+ 55* 317 _+ 35*
20.0 177 _+ 34 129 _+ 43
40.0 321 _+118" 57_+11t
80.0 139 +_ 19 42 _+ 71"
*p < 0.05 compared with saline control.
n=4.
{ p < 0.05 compared with fasted group.
Normal corticosterone levels 10-60 ng/ml.
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FIG. 4. Cell counts recoverable from the pleural cavity of rats injected with rat IL-1 fl (-O-),
human IL-lfl (-,-) or human IL-I (-I-). There are no significant differences from the
saline treated controls with any protein at any concentration, n 3.
cell influx, fluid extravasation and IL-lfl levels was
investigated. Since the standard drugs dexa-
methasone and naproxen reduce cell and fluid
influx in this model,2’16 these were administered for
comparison. Cell influx in all the drug treated rats
was significantly increased compared with the saline
controls (1.5 x 106 cells/ml) and significantly less
than the level of the carrageenan controls
(1.45 x 108 cells/ml). The effects of dexamethasone
and naproxan are consistent with previous findings.
The ED30 values for cellular infiltration with orally
administered dexamethasone is 0.05 mg/kg, naprox-
en is 1.4mg/kg and piroxicam is 0.7 mg/kg,
indicating that these drugs are active in this model, is
Fluid volumes significantly decreased by approx-
imately 15% with IL-1/ levels remaining constant.
These data substantiate the involvement of several
mechanisms in the inflammatory process induced by
carrageenan, since individually none of the drugs
prevented the pro-inflammatory changes in the
pleural cavity.
The IL-1 receptor antagonist inhibits IL-1 by
binding to its receptors and has no apparent agonist
activity.
3 It has been shown to be active in several
septic shock models,16’7 increasing animal survival.
Administration of this protein does not completely
prevent IL-1/ influx or cell accumulation in the
pleural cavity in response to carrageenan. Meyers et
al. TM have reported that in rats fed ad libitum, the
rhIL-lra decreased total cell influx in a dose
dependent manner from 28% to 74% at doses
ranging from 0.3-10 mg/kg. In our model using
rats fed ad libitum, the rhlL-lra did decrease cell
influx, but by no more than 45%. The response in
the fasted animals was shown to be more variable,
not dose dependent and the maximum inhibition of
38 Mediators of Inflammation. Vol 2.1993
cell influx was approximately 35%. In general, the
IL-lfl levels in the pleural cavity were higher in the
fasted animals than in the fed ones. Therefore,
fasting and carrageenan induced inflammation
together lead to a response that requires more
rhlL-lra to down-regulate it.
IL-1 is one of the key mediators of the
brain-endocrine immune response to stress.
9 IL-1
activates the hypothalamic-pituitary-adrenal axis;
its effect on this axis appears to be mediated by
activation of secretion of corticotropin releasing
factor, leading to the release of ACTH and
corticosterone.2’2 In stress there are elevations in
plasma corticosterone and IL-1 levels in rats. TM We
stressed our animals by fasting them for 16 h prior
to administration of the carrageenan. We hypothe-
sized that this stress should increase plasma
corticosterone levels and may increase IL-1 levels
in the pleural cavity resulting in higher doses of the
rhIL-lra to down-regulate this response. The
rhlL-lra should lead to a reduction in the IL-1
induction of plasma corticosterone levels. Carragee-
nan does induce increased plasma corticosterone
levels compared with controls whether the animals
are fed or fasted. We observed more variability in
the response of fasted animals to the rhIL-lra. In
the rats fed ad libitum, plasma corticosterone levels
decreased in a dose dependent manner as the dose
of the rhIL-lra increased, suggesting that IL-1-
induced corticosterone secretion was effectively
inhibited. Corticosterone levels in the food
deprived animals did not return to normal. IL-1
levels in the pleural cavity only returned toward the
saline controls at the highest dose of the receptor
antagonist. These findings demonstrate that 16 h of
food deprivation does play a role in the responseIL- in rat pleurisy
of the animal to carrageenan, both in its plasma
corticosterone and pleural cavity IL-lfl levels, and
suggest that IL-1 may mediate this response.
In order to investigate the role of IL-1 as a
pro-inflammatory agent in the pleurisy model, we
injected human and rat IL-1/ and human IL-I
directly into the pleural cavity. When the human
and rat IL-10 and fl were injected across a wide
range, there was no inflammatory response in the
pleural cavity, as determined by changes in cell
influx or fluid volume. These data suggest that IL-1
is an important component in the amplification of
inflammation, but that it is not the initiator of the
inflammatory events. In this model several
inflammatory mediators including histamine, brady-
kinin and thromboxane have been detected in the
pleural exudates of rats. The role these mediators
play in exudate formation is unclear, since the
injection of any one of these mediators alone does
not result in a significant fluid or cellular response.
Thus, the observation that IL-1 per se is not a
pro-inflammagen is consistent with the findings for
other mediators. The combination of one or more
of such mediators may be responsible for the
inflammation.
The present work demonstrates that levels of
IL-lfl are found in the pleural cavity of the
carrageenan injected rats in association with
increased cellular influx and oedema. The stress of
16h of food deprivation also influences the
response of the animals to the carrageenan induced
injury, indicated by increased plasma corticosterone
and pleural IL-lfl levels. However, human IL-10
and fl and rat IL-lfi are not pro-inflammatory
agents when injected individually into the rat
pleural cavity under the conditions we used,
suggesting that IL-1 per se is not the initiator of cell
influx and fluid extravasation in this model.
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